Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments

NCT06799637 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Pancreatic Carcinoma
Ovarian Cancer
Cervical Cancers

Interventions

DRUG: XNW28012

Sponsor

Evopoint Biosciences Inc.